Cargando…

CTLA-4 correlates with immune and clinical characteristics of glioma

BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fangkun, Huang, Jing, Liu, Xuming, Cheng, Quan, Luo, Chengke, Liu, Zhixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945521/ https://www.ncbi.nlm.nih.gov/pubmed/31911758 http://dx.doi.org/10.1186/s12935-019-1085-6

Ejemplares similares

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2020)

Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma
por: Liu, Fangkun, et al.
Publicado: (2019)

Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Correction to: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
por: Zhang, Hao, et al.
Publicado: (2021)

A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma
por: Xu, Shengchao, et al.
Publicado: (2020)

PDIA3 correlates with clinical malignant features and immune signature in human gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
por: Liu, Shiyi, et al.
Publicado: (2020)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

The characteristics of bone marrow-derived endothelial progenitor cells and their effect on glioma
por: Zhang, She-Hong, et al.
Publicado: (2012)

A Novel Mice Model for Studying the Efficacy and IRAEs of Anti-CTLA4 Targeted Immunotherapy
por: Xu, Shengchao, et al.
Publicado: (2021)

Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness
por: Xu, Shengchao, et al.
Publicado: (2020)

PD-L1-related IncRNAs are associated with malignant characteristics and immune microenvironment in glioma
por: Xia, Zhiwei, et al.
Publicado: (2023)

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
por: Liu, Jingkai, et al.
Publicado: (2021)

Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
por: Li, Chenglong, et al.
Publicado: (2022)

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
por: Zhang, Nan, et al.
Publicado: (2022)

Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells
por: Zhang, Chaochao, et al.
Publicado: (2021)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Skp2 modulates proliferation, senescence and tumorigenesis of glioma
por: Wu, Juan, et al.
Publicado: (2020)

Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2021)

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
por: Chai, Rui-Chao, et al.
Publicado: (2019)

TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
por: Chen, Rui, et al.
Publicado: (2021)

p62 acts as an oncogene and is targeted by miR-124-3p in glioma
por: Deng, Danni, et al.
Publicado: (2019)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
por: Wang, Zeyu, et al.
Publicado: (2022)

Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022)

MiR-4310 induced by SP1 targets PTEN to promote glioma progression
por: Wu, Zhiyong, et al.
Publicado: (2020)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
por: Lu, Jiacheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6m6p1k824rgghioen5rouf713n